Madrigal Pharmaceuticals Operating Expenses 2010-2024 | MDGL
Madrigal Pharmaceuticals operating expenses for the twelve months ending September 30, 2024 were $0.625B, a 79.24% increase year-over-year.
- Madrigal Pharmaceuticals annual operating expenses for 2023 were $0.38B, a 29.61% increase from 2022.
- Madrigal Pharmaceuticals annual operating expenses for 2022 were $0.294B, a 21.07% increase from 2021.
- Madrigal Pharmaceuticals annual operating expenses for 2021 were $0.242B, a 17.33% increase from 2020.